Inspire Medical Systems (INSP) Cash & Equivalents (2017 - 2026)

Inspire Medical Systems has disclosed Cash & Equivalents across 10 years of filings, most recently posting $98.9 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $98.9 million, up 83.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.9 million (up 83.61% YoY), and the FY2025 annual result was $104.8 million, down 30.19% from the prior year.
• Cash & Equivalents came in at $98.9 million for Q1 2026 at Inspire Medical Systems, down from $104.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $467.1 million in Q2 2023 to a low of $53.9 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $185.5 million (2023), against an average of $224.3 million.
• Across the five-year window, Cash & Equivalents jumped 150.34% in 2023 and sank 69.28% in 2025, its largest moves.
• Inspire Medical Systems' Cash & Equivalents stood at $441.6 million in 2022, then plunged by 57.98% to $185.5 million in 2023, then fell by 19.07% to $150.2 million in 2024, then tumbled by 30.19% to $104.8 million in 2025, then decreased by 5.61% to $98.9 million in 2026.
• The last three Cash & Equivalents figures came in at $98.9 million (Q1 2026), $104.8 million (Q4 2025), and $112.8 million (Q3 2025), per Business Quant data.